Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Drug and gene delivery to the back of the eye: from bench to bedside.

Literature DB >> 24777644

Drug and gene delivery to the back of the eye: from bench to bedside.

Cheryl L Rowe-Rendleman¹, Shelley A Durazo, Uday B Kompella, Kay D Rittenhouse, Adriana Di Polo, Alan L Weiner, Hans E Grossniklaus, Muna I Naash, Alfred S Lewin, Alan Horsager, Henry F Edelhauser.

Abstract

Keywords: drug delivery; gene therapy; nanoparticle; retina; translational medicine

Mesh：

Substances：

Year: 2014 PMID： 24777644 PMCID： PMC4004426 DOI： 10.1167/iovs.13-13707

Source DB: PubMed Journal: Invest Ophthalmol Vis Sci ISSN： 0146-0404 Impact factor: 4.799

× No keyword cloud information.

69 in total

Review 1. Topical and systemic drug delivery to the posterior segments.

Authors: Patrick M Hughes; Orest Olejnik; Joan-En Chang-Lin; Clive G Wilson
Journal: Adv Drug Deliv Rev Date: 2005-11-10 Impact factor: 15.470

2. Millisecond-timescale, genetically targeted optical control of neural activity.

Authors: Edward S Boyden; Feng Zhang; Ernst Bamberg; Georg Nagel; Karl Deisseroth
Journal: Nat Neurosci Date: 2005-08-14 Impact factor: 24.884

3. Commentary: an aye for eye gene therapy.

Authors: Jean Bennett
Journal: Hum Gene Ther Date: 2006-02 Impact factor: 5.695

4. Vitamin A palmitate and aciclovir biodegradable microspheres for intraocular sustained release.

Authors: C Martínez-Sancho; R Herrero-Vanrell; S Negro
Journal: Int J Pharm Date: 2006-07-14 Impact factor: 5.875

Review 5. Timing and computation in inner retinal circuitry.

Authors: Stephen A Baccus
Journal: Annu Rev Physiol Date: 2007 Impact factor: 19.318

Review 6. Perspective on genes and mutations causing retinitis pigmentosa.

Authors: Stephen P Daiger; Sara J Bowne; Lori S Sullivan
Journal: Arch Ophthalmol Date: 2007-02

7. Parallel processing in retinal ganglion cells: how integration of space-time patterns of excitation and inhibition form the spiking output.

Authors: Botond Roska; Alyosha Molnar; Frank S Werblin
Journal: J Neurophysiol Date: 2006-03-01 Impact factor: 2.714

8. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.

Authors: Michael R Robinson; Susan S Lee; Hyuncheol Kim; Stephanie Kim; Robert J Lutz; Craig Galban; Peter M Bungay; Peng Yuan; Nam Sun Wang; Jonghyeon Kim; Karl G Csaky
Journal: Exp Eye Res Date: 2005-09-15 Impact factor: 3.467

9. Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration.

Authors: Anding Bi; Jinjuan Cui; Yu-Ping Ma; Elena Olshevskaya; Mingliang Pu; Alexander M Dizhoor; Zhuo-Hua Pan
Journal: Neuron Date: 2006-04-06 Impact factor: 17.173

10. Efficient non-viral ocular gene transfer with compacted DNA nanoparticles.

Authors: Rafal Farjo; Jeff Skaggs; Alexander B Quiambao; Mark J Cooper; Muna I Naash
Journal: PLoS One Date: 2006-12-20 Impact factor: 3.240

38 in total

1. Systemic treatment with a 5HT1a agonist induces anti-oxidant protection and preserves the retina from mitochondrial oxidative stress.

Authors: Manas R Biswal; Chulbul M Ahmed; Cristhian J Ildefonso; Pingyang Han; Hong Li; Hiral Jivanji; Haoyu Mao; Alfred S Lewin
Journal: Exp Eye Res Date: 2015-08-25 Impact factor: 3.467

2. Ocular disposition of ciprofloxacin from topical, PEGylated nanostructured lipid carriers: Effect of molecular weight and density of poly (ethylene) glycol.

Authors: Sai Prachetan Balguri; Goutham R Adelli; Karthik Yadav Janga; Prakash Bhagav; Soumyajit Majumdar
Journal: Int J Pharm Date: 2017-06-17 Impact factor: 5.875

Review 3. Vision from next generation sequencing: multi-dimensional genome-wide analysis for producing gene regulatory networks underlying retinal development, aging and disease.

Authors: Hyun-Jin Yang; Rinki Ratnapriya; Tiziana Cogliati; Jung-Woong Kim; Anand Swaroop
Journal: Prog Retin Eye Res Date: 2015-02-07 Impact factor: 21.198

Drug and gene delivery to the back of the eye: from bench to bedside.

Review 1. Topical and systemic drug delivery to the posterior segments.

2. Millisecond-timescale, genetically targeted optical control of neural activity.

3. Commentary: an aye for eye gene therapy.

4. Vitamin A palmitate and aciclovir biodegradable microspheres for intraocular sustained release.

Review 5. Timing and computation in inner retinal circuitry.

Review 6. Perspective on genes and mutations causing retinitis pigmentosa.

7. Parallel processing in retinal ganglion cells: how integration of space-time patterns of excitation and inhibition form the spiking output.

8. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.

9. Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration.

10. Efficient non-viral ocular gene transfer with compacted DNA nanoparticles.

1. Systemic treatment with a 5HT1a agonist induces anti-oxidant protection and preserves the retina from mitochondrial oxidative stress.

2. Ocular disposition of ciprofloxacin from topical, PEGylated nanostructured lipid carriers: Effect of molecular weight and density of poly (ethylene) glycol.

Review 3. Vision from next generation sequencing: multi-dimensional genome-wide analysis for producing gene regulatory networks underlying retinal development, aging and disease.

4. In vitro and in vivo rescue of aberrant splicing in CEP290-associated LCA by antisense oligonucleotide delivery.

Review 5. Advancements in Understanding Immunogenicity of Biotherapeutics in the Intraocular Space.

6. Inhibition of thyroid hormone receptor locally in the retina is a therapeutic strategy for retinal degeneration.

Review 7. Nanomedicine in the application of uveal melanoma.

Review 8. The suprachoroidal space as a route of administration to the posterior segment of the eye.

Review 9. Recent perspectives on the delivery of biologics to back of the eye.

10. Targeting iodothyronine deiodinases locally in the retina is a therapeutic strategy for retinal degeneration.